Skip to content

Drug interactions

Brentuximab vedotin + Tabelecleucel

Severity: Moderate

Brentuximab vedotin and Tabelecleucel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brentuximab vedotin is cytotoxic to CD30-positive cells and may impair the activity or survival of infused T cells. This could reduce tabelecleucel efficacy.

What this interaction means in plain words

Brentuximab vedotin and Tabelecleucel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab vedotin belongs to Oncology; Tabelecleucel belongs to Oncology.

Evidence level: Low

Why it happens

Cytotoxic and immunomodulatory effects of brentuximab vedotin may damage the infused EBV-specific T cells.

What to do

Allow an adequate washout after brentuximab vedotin before giving tabelecleucel, following the product labeling.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab vedotin and Tabelecleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab vedotin with Tabelecleucel?

MediHelp rates the interaction as moderate. Brentuximab vedotin and Tabelecleucel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Brentuximab vedotin is cytotoxic to CD30-positive cells and may impair the activity or survival of infused T cells. This could reduce tabelecleucel efficacy.

How serious is the interaction between Brentuximab vedotin and Tabelecleucel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Allow an adequate washout after brentuximab vedotin before giving tabelecleucel, following the product labeling.

What other medicines interact with Tabelecleucel?

MediHelp also lists interactions of Tabelecleucel with, for example, Prednisone. The full list is on the Tabelecleucel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in